Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
15.22
+0.24 (1.60%)
Jun 9, 2026, 4:00 PM EDT - Market closed

Jade Biosciences Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Jade Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $49. The average 1-year stock price forecast is 221.94% higher than the current stock price, while the lowest is $40 (+162.81%) and the highest is $74 (+386.20%).

Price Target: $49 (+221.94%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$40$49$45$74
Change+162.81%+221.94%+195.66%+386.20%

Analyst Ratings

The average analyst rating for Jade Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy779999
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total779999

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wedbush
Wedbush
Buy
Maintains
$34$45
BuyMaintains$34$45+195.66%Jun 2, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$32$47
BuyReiterates$32$47+208.80%Jun 2, 2026
BTIG
BTIG
Buy
Maintains
$39$74
BuyMaintains$39$74+386.20%Jun 2, 2026
Jefferies
Jefferies
Buy
Maintains
$40
BuyMaintains$40+162.81%Jun 1, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$24$42
BuyMaintains$24$42+175.95%Jun 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---
Operating Income
-64.48M-113.54M-179.11M
Net Income
-93.96M-127.41M-172.25M
Free Cash Flow
--61.35M-159.50M
No. Analysts
--8

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-